Literature DB >> 8033486

Concentration- or effect-controlled clinical trials with sparse data.

G Levy1, W F Ebling, A Forrest.   

Abstract

Mesh：

Year:  1994        PMID： 8033486     DOI： 10.1038/clpt.1994.93

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN： 0009-9236            Impact factor:   6.875


× No keyword cloud information.
  14 in total

Review 1.  Concentration-controlled or effect-controlled trials: useful alternatives to conventional dose-controlled trials?

Authors:  A Grahnén; M O Karlsson
Journal:  Clin Pharmacokinet       Date:  2001       Impact factor: 6.447

Review 2.  Drug-gene interactions between genetic polymorphisms and antihypertensive therapy.

Authors:  Hedi Schelleman; Bruno H Ch Stricker; Anthonius De Boer; Abraham A Kroon; Monique W M Verschuren; Cornelia M Van Duijn; Bruce M Psaty; Olaf H Klungel
Journal:  Drugs       Date:  2004       Impact factor: 9.546

Review 3.  Integrated pharmacokinetics and pharmacodynamics in drug development.

Authors:  Jasper Dingemanse; Silke Appel-Dingemanse
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

Review 4.  Best practice in therapeutic drug monitoring.

Authors:  A S Gross
Journal:  Br J Clin Pharmacol       Date:  1998-08       Impact factor: 4.335

5.  Feasibility of effect-controlled clinical trials of drugs with pharmacodynamic hysteresis using sparse data.

Authors:  W F Ebling; Y Matsumoto; G Levy
Journal:  Pharm Res       Date:  1996-12       Impact factor: 4.200

Review 6.  Predicting effective drug concentrations for individual patients. Determinants of pharmacodynamic variability.

Authors:  G Levy
Journal:  Clin Pharmacokinet       Date:  1998-04       Impact factor: 6.447

Review 7.  Pharmacokinetic-pharmacodynamic relationships of H1-antihistamines.

Authors:  J P Desager; Y Horsmans
Journal:  Clin Pharmacokinet       Date:  1995-05       Impact factor: 6.447

Review 8.  Concentration-controlled trials. What does the future hold?

Authors:  A Johnston; D W Holt
Journal:  Clin Pharmacokinet       Date:  1995-02       Impact factor: 6.447

Review 9.  The target concentration approach to clinical drug development.

Authors:  N H Holford
Journal:  Clin Pharmacokinet       Date:  1995-11       Impact factor: 6.447

10.  Scientific and ethical concerns in clinical trials in Alzheimer's patients: the bridging study.

Authors:  N R Cutler; J J Sramek
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.